A Study to Learn About Three Forms of The Study Medicine (Ritlecitinib) in Healthy Adults

Clinical trial NCT06172348 · COMPLETED

Trial details

NCT number: NCT06172348
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2024-02-01
Primary completion: 2024-03-28
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.